Clinical trials of PCI

Clinical trials of PCI and meta-analysis are available for the following clinical conditions:

acute myocardial infarction

acute myocardial infarction, myocardial revascularization, all type of patients

primary PCI vs accelerated t-PA : C-PORT, 2002 -
systematic PCI (+stent) vs no systematic PCI : WEST, 2006 - CAPITAL AMI, 2005 - GRACIA-1, 2004 - SIAM III, 2002 - PRAGUE, 2000 -
primary PCI vs thrombolytic therapy : senior PAMI, 2005 -

acute myocardial infarction, PCI, all type of patients

acute myocardial infarction, PCI, Elderly patients

primary PCI vs thrombolytic therapy : senior PAMI, 2005 -

acute myocardial infarction, myocardial revascularization, Elderly patients

primary PCI vs thrombolytic therapy : senior PAMI, 2005 -

coronary artery disease

coronary artery disease, myocardial revascularization, all type of patient

PCI vs CABG : MASS II, 2007 - COMBAT, 0 - Korean Randomized Study, 0 - REVASCULARIZE, 0 - AWESOME, 2001 -
CABG or PCI vs medical treatment : BARI 2D, 2009 - AVERT, 1995 - COURAGE, 2007 - MASS II, 2007 - Dakik, 1998 - ALKK, 2003 - Hambrecht, 2004 - Bech, 2001 - TIME, 2001 -

coronary artery disease, myocardial revascularization, diabetic patients

CABG or PCI vs medical treatment : BARI 2D, 2009 -

coronary artery disease, myocardial revascularization, multivessels disease

PCI vs CABG : AWESOME, 2001 -

coronary artery disease, revascularization with drug eluting stent, all type of patients

PCI vs CABG : REVASCULARIZE, 0 - COMBAT, 0 - Korean Randomized Study, 0 -

coronary artery disease, revascularization with drug eluting stent, unparticular patients

PCI vs CABG : COMBAT, 0 - Korean Randomized Study, 0 - REVASCULARIZE, 0 -

stable angina

stable angina, myocardial revascularization, all type of patient

PCI vs CABG : MASS II, 2007 - AWESOME, 2001 -
CABG or PCI vs medical treatment : BARI 2D, 2009 - AVERT, 1995 - COURAGE, 2007 - MASS II, 2007 - Dakik, 1998 - ALKK, 2003 - Hambrecht, 2004 - Bech, 2001 - TIME, 2001 -

stable angina, myocardial revascularization, single vessel disease

PCI with or without stent vs medical treatment : ALKK, 2003 -

stable angina, myocardial revascularization, multivessels disease

PCI vs CABG : AWESOME, 2001 -
PCI with or without stent vs medical treatment : AVERT, 1995 - MASS II, 2007 - Dakik, 1998 - Hambrecht, 2004 - Bech, 2001 -

stable angina, myocardial revascularization, diabetic patients

CABG or PCI vs medical treatment : BARI 2D, 2009 -

Entry terms: PCI34051, PCI 34051, PCI34051, PCI-34051, PCI 2050, PCI2050, PCI-2050, CRA 024781, CRA024781, CRA-024781, PCI 24781, PCI24781, PCI-24781, PCI 2010, PCI2010, PCI-2010, PCI 2000, PCI-2000, PCI2000, motexafin lutetium, lutetium texaphyrin, lutex, Lu-Tex, PCI 0123, PCI-0123, Lutrin, Optrin, Dashurin, human, CSN7 protein, Arabidopsis, COP9 signalosome subunit 7, Arabidopsis, PCI domain-containing protein, Drosophila, dmPCID2 protein, Drosophila, motexafin gadolinium, gadolinium texaphyrin, Gd(III) texaphyrin, gadolinium texaphyrin complex, PCI-0120, Xcytrin, vanadium iodoperoxidase, vanadium-dependent iodide peroxidase, PcI vanadium-dependent iodoperoxidase, myristoylated-GLFRKAMRLRFPV, myr-PCI(F), myristoylated-GLYRKAMRLRYPV, myr-PCI(Y), trypsin carboxypeptidase peptide inhibitor, TCPI, 4-nitrophenyl N-(succinyl-alanyl-alanyl-prolylmethyl)-N-isopropylcarbamate, PCI-NSAAPM, p-nitrophenyl N-(succinyl-Ala-Ala-Pro-Me)-N-IPC